Astrea Bioseparations
Chris Sadler has extensive experience in the biopharmaceutical sector, currently serving as Resin Development Lead at Astrea Bioseparations since March 2006. In this role, Chris collaborates with Product and Project Management Leads to translate product concepts into market-ready solutions and supports the Product Delivery Road Map for New Product Initiatives. Previously, Chris held positions such as Chemistry Subject Matter Expert, Chemistry Manager, Research Scientist, and Research Assistant within the company, contributing significantly to ligand discovery, product development, and manufacturing process optimization for GMP-compliant chromatography media, particularly in the context of Cell and Gene Therapy applications. Chris began a professional career in finance as an Accounts Payable Clerk at Banner Business Supplies and holds an MChem degree in Chemistry from the University of East Anglia.
This person is not in any offices
Astrea Bioseparations
1 followers
Since 1987, Astrea Bioseparations has been pioneering the design, development and manufacture of affinity purification technology for lab-scale and industrial-scale bioprocessing. With over 25 years experience and success in the development of affinity products and design of new custom adsorbents, Astrea is a world leader in its field. Astrea Bioseparations has sales and support offices in North America and Europe, R&D facilities in Cambridge, UK and manufacturing facilities located on the Isle of Man, British Isles and Joliette, QC, Canada ensuring that we are able to meet your needs and support your application wherever you are. OUR EXPERTISE: • Extensive range of bioseparation products • Custom designed chromatography adsorbents • Over 25 years experience & success • Cost effective solutions • Proven Mimetic Ligand™ technology • Dedicated professional service • Full technical support & in-house training • Experts in adsorbent development & downstream process optimization • Established manufacturing facility (ISO 9001)